Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Germany Clear all

275 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20022
20038
200415
200513
200622
200710
200825
200920
201024
201113
201214
201313
201414
20158
20168
201710
20186
20195
20205
20214
20222
20235
20244
20255
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed236
Terminated18
Recruiting11
Active, not recruiting7
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S52
AstraZeneca32
Eli Lilly and Company28
Sanofi28
Boehringer Ingelheim19
Novartis Pharmaceuticals17
Novartis12
Takeda12
Hoffmann-La Roche11
GlaxoSmithKline10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2275
Diabetes Mellitus80
Obesity18
Glucose Metabolism Disorders14
Overweight14
Cardiovascular Diseases13
Dyslipidemias10
Hyperglycemia8
Renal Insufficiency, Chronic7
Hypertension6

Trials

Showing 1 to 25 of 275. Each trial links to its page on Pharma Observatory.

175 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.